136 results on '"Choi, Hyeong-wook"'
Search Results
2. Discovery and characterization of stereodefined PMO-gapmers targeting tau
3. Total Synthesis of Eribulin, a Macrocyclic Ketone Analogue of Halichondrin B, via Prins Macrocyclization.
4. Discovery and characterization of stereodefined PMO-gapmers targeting tau
5. Building C(sp3)-rich complexity by combining cycloaddition and C–C cross-coupling reactions
6. Data from Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
7. Supplemental Figure Legends from Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
8. Supplemental Figures S1-S6 and Table S1 from Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
9. Supplemental Materials and Methods from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
10. Supplemental Figure 2 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
11. Supplemental Figure Legends from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
12. Supplemental Figure 3 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
13. Supplemental Table 1 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
14. Data from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
15. Supplemental Figure 4 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
16. Supplemental Figure 1 from M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
17. The Effects of Immersive Virtual Reality Training on Dynamic Balance and Gait of Stroke Patients
18. Analysis of the origin of gravels and sedimentary environment in the Quaternary Baeguiri Formation, Hantangang River Geopark
19. A Study on Chinese Poetry on the Theme of Ahn Jung-geun Ⅱ : Focusing on Special Other or Third-party"s Perceptions and Emotional Expressions
20. Development and Commercialization of a Fully Synthetic Marine Natural Product Analogue, Halaven® (Eribulin Mesylate)
21. Front Cover: E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity (ChemMedChem 11/2021)
22. E7766, a Macrocycle‐Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan‐Genotypic Activity
23. Abstract 592: Demonstration of E7766, a novel STING agonist, as a potent immunotherapy in BCG-insensitive non-muscle invasive bladder cancer models via intravesical administration
24. Abstract 4456: Discovery of E7766: A representative of a novel class of macrocycle-bridged STING agonists (MBSAs) with superior potency and pan-genotypic activity
25. A Study on Liang Qi-chao`s Conceptualization of Ideal National Character through the Writing of 『China`s Way of the Warrior』
26. Synthesis of a Polycyclic Halichondrin C1–C14 Fragment via Intermolecular Oxy-Michael/Trans-Ketalization
27. Synthesis of the Halichondrin C1–C15 Fragment from a Halaven C27–C35 Byproduct: Stereospecific Intramolecular Kishi Reduction
28. Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
29. Prins Reaction of Homoallenyl Alcohols: Access to Substituted Pyrans in the Halichondrin Series
30. M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
31. Development of a Scalable Synthetic Route towards a Thrombin Inhibitor, LB30057
32. Synthesis of a Polycyclic Halichondrin C1–C14 Fragment via Intermolecular Oxy-Michael/Trans-Ketalization.
33. Stereoselective Total Synthesis of the Natural (+)-Lasonolide A
34. The Chemical Development of LB71350
35. Efficient Synthesis of (3R,5S)-3,5,6-Trihydroxyhexanoic Acid Derivative as a Chiral Side Chain of Statins
36. M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
37. Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61
38. Efficient Synthesis of Clitocine via 1,3-N (endo) to N (exo) Migration: A Revision to Kini’s Work
39. Efficient and Scalable Synthesis of Ethyl 2,6-Dichloro-5-Fluoronicotinoyl Acetate Using the Blaise Reaction as a Key Step1
40. A Stereodivergent Synthesis of Hydroxyethylene Dipeptide Isostere via Highly Diastereoselective Epoxidation
41. Building C(sp3)-rich complexity by combining cycloaddition and C-C cross-coupling reactions.
42. Total Synthesis of Eribulin, a Macrocyclic Ketone Analogue of Halichondrin B, via Prins Macrocyclization
43. ChemInform Abstract: Asymmetric Synthesis of N-Acetylneuraminic Acid
44. EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
45. Efficient Activation of Zinc: Application of the Blaise Reaction to an Expedient Synthesis of a Statin Intermediate
46. A Stereoselective Synthesis of the C15—C25 Subunit (I) of (+)-Iasonolide A (II)
47. Process Development of Halaven®: Synthesis of the C14-C35 Fragment via Iterative Nozaki-Hiyama-Kishi Reaction-Williamson Ether Cyclization
48. ChemInform Abstract: Asymmetric Synthesis of N-Acetylneuraminic Acid.
49. Analysis of Nursing-related Content Portrayed in Middle and High School Textbooks under the National Common Basic Curriculum in Korea
50. Efficient Synthesis of (3R,5S)-3,5,6-Trihydroxyhexanoic Acid Derivative as a Chiral Side Chain of Statins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.